chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: UNK, UNK
Symptoms: Biopsy, Eye swelling, Inflammation, Periorbital swelling
Clinical narrative: eyes puffy and swollen - inflamation still almost year later
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Arthralgia, Dizziness, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Severe arm and shoulder pain to the extent that I could not move any part of my arm, hand, fingers without excruciating pain. Swollen at injection site, warm to the touch. Slight dizziness and nausea. Ibruprophen not helpful with pain but icing on injection site and surrounding area made a significant difference in the pain.
Age: 65.0
Sex: F
Vaccine: PPV
Symptoms: Nausea, Pain, Pain in extremity
Clinical narrative: Severe arm and shoulder pain to the extent that I could not move any part of my arm, hand, fingers without excruciating pain. Swollen at injection site, warm to the touch. Slight dizziness and nausea. Ibruprophen not helpful with pain but icing on injection site and surrounding area made a significant difference in the pain.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: Pt given 2nd dose Moderna on day 21.  No adverse effects noted
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness and tingling in left hand developed the day after injection
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram normal, Discomfort, Facial pain, Hypoaesthesia, Hypoaesthesia oral
Clinical narrative: 12 hours later after receiving the vaccine I could feel pain and a tingling feeling moving from the injection site up my arm to my neck and then to my right cheek. It was uncomfortable and it lasted for about 3 days. I had to take medicine once and then it went away. I got the next dose on February 26, 2021 (Lot #: EN6202). I got it in my left arm, and I didn't have any problems with it. In mid June 2021, I started having bad episodes of cheek pain, congestion, and teeth pain. I went to about 3 different doctors. They all thought it was a sinus infection. I took some antibiotics, but that didn't help. I went back to my dentist in June 2021, and I told them there was something wrong with the right side of my face and teeth area. They decided to do a root canal. On October 14, 2021, I went to have the root canal. When the dentist went half way through it, they saw a cracked tooth. They said they wouldn't be able to do the root canal because my tooth would need to removed. On October 22, 2021, I had to get my tooth pulled. Then on October 29, 2021, I had to go back to the doctor because of the pain I was in. They gave me steroids that did help. My cheek and gums are still numb. I saw an ENT doctor on February 21, 2022 because the numbness on my face had spread from the center of my right cheek to the bottom of my eye and upper gum area. I have nasal congestion. My doctor told me that if I notice paralysis in my face then I need to come back in. The numbness is only on the right side.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Injection site paraesthesia, Nasal congestion, Neck pain, Pain in extremity
Clinical narrative: 12 hours later after receiving the vaccine I could feel pain and a tingling feeling moving from the injection site up my arm to my neck and then to my right cheek. It was uncomfortable and it lasted for about 3 days. I had to take medicine once and then it went away. I got the next dose on February 26, 2021 (Lot #: EN6202). I got it in my left arm, and I didn't have any problems with it. In mid June 2021, I started having bad episodes of cheek pain, congestion, and teeth pain. I went to about 3 different doctors. They all thought it was a sinus infection. I took some antibiotics, but that didn't help. I went back to my dentist in June 2021, and I told them there was something wrong with the right side of my face and teeth area. They decided to do a root canal. On October 14, 2021, I went to have the root canal. When the dentist went half way through it, they saw a cracked tooth. They said they wouldn't be able to do the root canal because my tooth would need to removed. On October 22, 2021, I had to get my tooth pulled. Then on October 29, 2021, I had to go back to the doctor because of the pain I was in. They gave me steroids that did help. My cheek and gums are still numb. I saw an ENT doctor on February 21, 2022 because the numbness on my face had spread from the center of my right cheek to the bottom of my eye and upper gum area. I have nasal congestion. My doctor told me that if I notice paralysis in my face then I need to come back in. The numbness is only on the right side.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Respiratory tract congestion, Tooth extraction, Toothache
Clinical narrative: 12 hours later after receiving the vaccine I could feel pain and a tingling feeling moving from the injection site up my arm to my neck and then to my right cheek. It was uncomfortable and it lasted for about 3 days. I had to take medicine once and then it went away. I got the next dose on February 26, 2021 (Lot #: EN6202). I got it in my left arm, and I didn't have any problems with it. In mid June 2021, I started having bad episodes of cheek pain, congestion, and teeth pain. I went to about 3 different doctors. They all thought it was a sinus infection. I took some antibiotics, but that didn't help. I went back to my dentist in June 2021, and I told them there was something wrong with the right side of my face and teeth area. They decided to do a root canal. On October 14, 2021, I went to have the root canal. When the dentist went half way through it, they saw a cracked tooth. They said they wouldn't be able to do the root canal because my tooth would need to removed. On October 22, 2021, I had to get my tooth pulled. Then on October 29, 2021, I had to go back to the doctor because of the pain I was in. They gave me steroids that did help. My cheek and gums are still numb. I saw an ENT doctor on February 21, 2022 because the numbness on my face had spread from the center of my right cheek to the bottom of my eye and upper gum area. I have nasal congestion. My doctor told me that if I notice paralysis in my face then I need to come back in. The numbness is only on the right side.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Anticoagulation drug level above therapeutic, Asthenia, Blood glucose normal, Blood magnesium decreased, COVID-19
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 12/30/21 (EL0340) Pfizer Dose 2 1/20/21 (EL0140) COVID Positive 10/16/21  10/16/21: Patient is a 57-year-old male who presents from his nursing home with some reported hypoxia with the patient having a room air saturation of 79% earlier today. Patient was subsequently placed on 2 L of supplemental nasal cannula oxygen and transferred to the emergency room for further treatment and evaluation.  Patient himself did not necessarily feel any increasing shortness of breath or dyspnea but does note some increased generalized weakness recently.  For the past 4 days prior to arrival the patient had some decreased appetite and decreased fluid intake recently.  Patient has not voided in roughly 36 hours and has refused a Foley catheter, patient has also refused hospice previously.  Patient has an extensive medical history which was discussed reviewed today as well as reviewing the patient's current medications.  Patient's previous hospitalizations and acute rehabilitative courses have been reviewed.  Laboratory studies, imaging studies, vital signs, current medications and emergency room records were personally reviewed.  Patient has been vaccinated for COVID and did ultimately end up testing positive for COVID while in the emergency room.  10/20/21: 1. Bilateral COVID-19 pneumonia-patient was vaccinated fully for COVID-19 but has tested positive, was significantly hypoxic at the nursing home and is now on 2-3 L via nasal cannula. Completed a 5 day course of , Ascorbic acid, vitamin-D and zinc along with dexamethasone.   2. Acute hypoxia-patient maintaining normal oxygenation on 2-3 L via nasal cannula. Can continue at LTC.   3. Supratherapeutic INR-INR upon arrival is 7.3 with no obvious signs of bleeding, INR improved today at 5.6.  At therapeutic levels on discharge.   4. Hypomagnesemia-magnesium level is noted to be 1.6 today started the patient oral Mg++ at 400mg Po Bid   5. Elevated troponin-patient has an elevated troponin x2 at 0.05 and 0.04 with no complaints of chest pain.  Two EKG tracings have been reviewed which were negative x2 with no acute changes.  No events on telemetry with the patient having no chest pain, monitor for now.   6. Essential hypertension-patient was hypotensive upon arrival to the emergency room and is known to have a history of autonomic dysfunction and orthostatic hypotension.  At his baseline the patient is on midodrine at 10 mg p.o. t.i.d. which will be continued.   7. Type 2 diabetes-blood sugars have been reviewed which are overall stable, make no changes or adjustments but continue close monitoring.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Cardiac telemetry, Decreased appetite, Electrocardiogram normal, Fluid intake reduced
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 12/30/21 (EL0340) Pfizer Dose 2 1/20/21 (EL0140) COVID Positive 10/16/21  10/16/21: Patient is a 57-year-old male who presents from his nursing home with some reported hypoxia with the patient having a room air saturation of 79% earlier today. Patient was subsequently placed on 2 L of supplemental nasal cannula oxygen and transferred to the emergency room for further treatment and evaluation.  Patient himself did not necessarily feel any increasing shortness of breath or dyspnea but does note some increased generalized weakness recently.  For the past 4 days prior to arrival the patient had some decreased appetite and decreased fluid intake recently.  Patient has not voided in roughly 36 hours and has refused a Foley catheter, patient has also refused hospice previously.  Patient has an extensive medical history which was discussed reviewed today as well as reviewing the patient's current medications.  Patient's previous hospitalizations and acute rehabilitative courses have been reviewed.  Laboratory studies, imaging studies, vital signs, current medications and emergency room records were personally reviewed.  Patient has been vaccinated for COVID and did ultimately end up testing positive for COVID while in the emergency room.  10/20/21: 1. Bilateral COVID-19 pneumonia-patient was vaccinated fully for COVID-19 but has tested positive, was significantly hypoxic at the nursing home and is now on 2-3 L via nasal cannula. Completed a 5 day course of , Ascorbic acid, vitamin-D and zinc along with dexamethasone.   2. Acute hypoxia-patient maintaining normal oxygenation on 2-3 L via nasal cannula. Can continue at LTC.   3. Supratherapeutic INR-INR upon arrival is 7.3 with no obvious signs of bleeding, INR improved today at 5.6.  At therapeutic levels on discharge.   4. Hypomagnesemia-magnesium level is noted to be 1.6 today started the patient oral Mg++ at 400mg Po Bid   5. Elevated troponin-patient has an elevated troponin x2 at 0.05 and 0.04 with no complaints of chest pain.  Two EKG tracings have been reviewed which were negative x2 with no acute changes.  No events on telemetry with the patient having no chest pain, monitor for now.   6. Essential hypertension-patient was hypotensive upon arrival to the emergency room and is known to have a history of autonomic dysfunction and orthostatic hypotension.  At his baseline the patient is on midodrine at 10 mg p.o. t.i.d. which will be continued.   7. Type 2 diabetes-blood sugars have been reviewed which are overall stable, make no changes or adjustments but continue close monitoring.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Hypomagnesaemia, Hypotension, Hypoxia, International normalised ratio increased, Micturition disorder
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 12/30/21 (EL0340) Pfizer Dose 2 1/20/21 (EL0140) COVID Positive 10/16/21  10/16/21: Patient is a 57-year-old male who presents from his nursing home with some reported hypoxia with the patient having a room air saturation of 79% earlier today. Patient was subsequently placed on 2 L of supplemental nasal cannula oxygen and transferred to the emergency room for further treatment and evaluation.  Patient himself did not necessarily feel any increasing shortness of breath or dyspnea but does note some increased generalized weakness recently.  For the past 4 days prior to arrival the patient had some decreased appetite and decreased fluid intake recently.  Patient has not voided in roughly 36 hours and has refused a Foley catheter, patient has also refused hospice previously.  Patient has an extensive medical history which was discussed reviewed today as well as reviewing the patient's current medications.  Patient's previous hospitalizations and acute rehabilitative courses have been reviewed.  Laboratory studies, imaging studies, vital signs, current medications and emergency room records were personally reviewed.  Patient has been vaccinated for COVID and did ultimately end up testing positive for COVID while in the emergency room.  10/20/21: 1. Bilateral COVID-19 pneumonia-patient was vaccinated fully for COVID-19 but has tested positive, was significantly hypoxic at the nursing home and is now on 2-3 L via nasal cannula. Completed a 5 day course of , Ascorbic acid, vitamin-D and zinc along with dexamethasone.   2. Acute hypoxia-patient maintaining normal oxygenation on 2-3 L via nasal cannula. Can continue at LTC.   3. Supratherapeutic INR-INR upon arrival is 7.3 with no obvious signs of bleeding, INR improved today at 5.6.  At therapeutic levels on discharge.   4. Hypomagnesemia-magnesium level is noted to be 1.6 today started the patient oral Mg++ at 400mg Po Bid   5. Elevated troponin-patient has an elevated troponin x2 at 0.05 and 0.04 with no complaints of chest pain.  Two EKG tracings have been reviewed which were negative x2 with no acute changes.  No events on telemetry with the patient having no chest pain, monitor for now.   6. Essential hypertension-patient was hypotensive upon arrival to the emergency room and is known to have a history of autonomic dysfunction and orthostatic hypotension.  At his baseline the patient is on midodrine at 10 mg p.o. t.i.d. which will be continued.   7. Type 2 diabetes-blood sugars have been reviewed which are overall stable, make no changes or adjustments but continue close monitoring.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, Refusal of treatment by patient, SARS-CoV-2 test positive, Troponin increased, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 12/30/21 (EL0340) Pfizer Dose 2 1/20/21 (EL0140) COVID Positive 10/16/21  10/16/21: Patient is a 57-year-old male who presents from his nursing home with some reported hypoxia with the patient having a room air saturation of 79% earlier today. Patient was subsequently placed on 2 L of supplemental nasal cannula oxygen and transferred to the emergency room for further treatment and evaluation.  Patient himself did not necessarily feel any increasing shortness of breath or dyspnea but does note some increased generalized weakness recently.  For the past 4 days prior to arrival the patient had some decreased appetite and decreased fluid intake recently.  Patient has not voided in roughly 36 hours and has refused a Foley catheter, patient has also refused hospice previously.  Patient has an extensive medical history which was discussed reviewed today as well as reviewing the patient's current medications.  Patient's previous hospitalizations and acute rehabilitative courses have been reviewed.  Laboratory studies, imaging studies, vital signs, current medications and emergency room records were personally reviewed.  Patient has been vaccinated for COVID and did ultimately end up testing positive for COVID while in the emergency room.  10/20/21: 1. Bilateral COVID-19 pneumonia-patient was vaccinated fully for COVID-19 but has tested positive, was significantly hypoxic at the nursing home and is now on 2-3 L via nasal cannula. Completed a 5 day course of , Ascorbic acid, vitamin-D and zinc along with dexamethasone.   2. Acute hypoxia-patient maintaining normal oxygenation on 2-3 L via nasal cannula. Can continue at LTC.   3. Supratherapeutic INR-INR upon arrival is 7.3 with no obvious signs of bleeding, INR improved today at 5.6.  At therapeutic levels on discharge.   4. Hypomagnesemia-magnesium level is noted to be 1.6 today started the patient oral Mg++ at 400mg Po Bid   5. Elevated troponin-patient has an elevated troponin x2 at 0.05 and 0.04 with no complaints of chest pain.  Two EKG tracings have been reviewed which were negative x2 with no acute changes.  No events on telemetry with the patient having no chest pain, monitor for now.   6. Essential hypertension-patient was hypotensive upon arrival to the emergency room and is known to have a history of autonomic dysfunction and orthostatic hypotension.  At his baseline the patient is on midodrine at 10 mg p.o. t.i.d. which will be continued.   7. Type 2 diabetes-blood sugars have been reviewed which are overall stable, make no changes or adjustments but continue close monitoring.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Malaise
Clinical narrative: At 0720, patient received her vaccine. She reported shortly after that she was not feeling too well. She was asked to lie down on the bed, help was called and her vitals were taken. Her vitals were as follows: HR 97 BP 156/93 and SPO 100%. While her vitals were taken, she was asked to describe how she felt. Her vitals were taken again at 0730: HR 110 BP 165/110 and SPO 100%. Help came and another set of vitals were taken at 0735: HR 101 BP 152/86 and SPO 100%. Patient was transferred to ED
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Impaired work ability, Tremor
Clinical narrative: At 0720, patient received her vaccine. She reported shortly after that she was not feeling too well. She was asked to lie down on the bed, help was called and her vitals were taken. Her vitals were as follows: HR 97 BP 156/93 and SPO 100%. While her vitals were taken, she was asked to describe how she felt. Her vitals were taken again at 0730: HR 110 BP 165/110 and SPO 100%. Help came and another set of vitals were taken at 0735: HR 101 BP 152/86 and SPO 100%. Patient was transferred to ED
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Induration, Injection site nodule, Injection site pain
Clinical narrative: The day of the vaccination I had a knot that came up at injection site and wrapped around to my underarm. It was hard, hot, burning and itchy all the time. I took ibuprofen for the pain and ice pack. I had it for a week and it is still a little tender at injection site. I'm also very tired. I have had several tests and nothing is wrong but I am extremely tired all the time and having difficulty sleeping.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Laboratory test, Nodule, Pain, Pruritus
Clinical narrative: The day of the vaccination I had a knot that came up at injection site and wrapped around to my underarm. It was hard, hot, burning and itchy all the time. I took ibuprofen for the pain and ice pack. I had it for a week and it is still a little tender at injection site. I'm also very tired. I have had several tests and nothing is wrong but I am extremely tired all the time and having difficulty sleeping.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: The day of the vaccination I had a knot that came up at injection site and wrapped around to my underarm. It was hard, hot, burning and itchy all the time. I took ibuprofen for the pain and ice pack. I had it for a week and it is still a little tender at injection site. I'm also very tired. I have had several tests and nothing is wrong but I am extremely tired all the time and having difficulty sleeping.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Fasciotomy, Inflammation, Leg amputation, Oedema, Peripheral artery occlusion
Clinical narrative: Patient had inflammatory response with swelling, edema requiring outpatient steroids.  She developed cold right foot and had a popliteal artery occlusion. She was admitted to an outside facility who attempted thrombectomy to popliteal artery in the right leg but were unsuccessful complicated by fasciotomies and lysis which was also unsuccessful.  She was transferred to the Hospital with complete occlusion of right popliteal artery despite multiple interventions and malperfusion to right leg for ~ 4 days.  She required an above the knee amputation on the right.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral coldness, Swelling, Thrombectomy
Clinical narrative: Patient had inflammatory response with swelling, edema requiring outpatient steroids.  She developed cold right foot and had a popliteal artery occlusion. She was admitted to an outside facility who attempted thrombectomy to popliteal artery in the right leg but were unsuccessful complicated by fasciotomies and lysis which was also unsuccessful.  She was transferred to the Hospital with complete occlusion of right popliteal artery despite multiple interventions and malperfusion to right leg for ~ 4 days.  She required an above the knee amputation on the right.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: There was no adverse reaction, vaccine was administered on 02/23/22 and vaccine expired on 02/17.
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Covid+
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram, Electrocardiogram
Clinical narrative: None stated.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, COVID-19, Chills, Cough, Dyspnoea
Clinical narrative: COVID Vaccine Breakthrough Case  J&J dose 7/27/21 (1808980) COVID Positive 10/11/21  10/15/21: History is obtained from patient as well as a personal review of records.  Patient is 47-year-old lady with known history of asthma, obesity pre diabetes and other medical problems.  She lives with her husband and 2 sons.  All 3 of them had COVID-19 in recent past.  Patient started having nasal congestion, chills and cough on 10/7/2021.  Symptoms have become worse in last 2 days.  She is coughing out sputum. Tan and pink in color.  Also reported back pain getting worse with cough and deep breathing.  Patient was advised by primary care provider to go to emergency department. She had test done for  SARS-CoV-2 on 10/11/2021.  It is positive.  She reports getting J&J vaccine.  10/17/21: Patient is a 47-year-old female who originally arrived to the emergency room secondary to some increasing nasal congestion, chills and cough as well as some increasing shortness of breath.  Patient was found to be COVID positive and is noted to have a history of being appropriately vaccinated.  Patient did briefly require some oxygen which ranges anywhere between 2-3 L via nasal cannula.  Patient was started on treatment for COVID-19 with remdesivir, steroids, antibiotics, vitamin-C, vitamin-D and zinc.  Patient did improve.  Patient also received nebulizers and dexamethasone.  On the morning of 10/17/2021 the patient was feeling better and was otherwise felt stable for discharge.  Patient's questions were answered to the best of my abilities and we did discuss review her medications, vital signs, laboratory studies, imaging studies and plan of care as well as the plan for follow-up.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Imaging procedure, Laboratory test, Nasal congestion, Painful respiration
Clinical narrative: COVID Vaccine Breakthrough Case  J&J dose 7/27/21 (1808980) COVID Positive 10/11/21  10/15/21: History is obtained from patient as well as a personal review of records.  Patient is 47-year-old lady with known history of asthma, obesity pre diabetes and other medical problems.  She lives with her husband and 2 sons.  All 3 of them had COVID-19 in recent past.  Patient started having nasal congestion, chills and cough on 10/7/2021.  Symptoms have become worse in last 2 days.  She is coughing out sputum. Tan and pink in color.  Also reported back pain getting worse with cough and deep breathing.  Patient was advised by primary care provider to go to emergency department. She had test done for  SARS-CoV-2 on 10/11/2021.  It is positive.  She reports getting J&J vaccine.  10/17/21: Patient is a 47-year-old female who originally arrived to the emergency room secondary to some increasing nasal congestion, chills and cough as well as some increasing shortness of breath.  Patient was found to be COVID positive and is noted to have a history of being appropriately vaccinated.  Patient did briefly require some oxygen which ranges anywhere between 2-3 L via nasal cannula.  Patient was started on treatment for COVID-19 with remdesivir, steroids, antibiotics, vitamin-C, vitamin-D and zinc.  Patient did improve.  Patient also received nebulizers and dexamethasone.  On the morning of 10/17/2021 the patient was feeling better and was otherwise felt stable for discharge.  Patient's questions were answered to the best of my abilities and we did discuss review her medications, vital signs, laboratory studies, imaging studies and plan of care as well as the plan for follow-up.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough, SARS-CoV-2 test positive, Sputum discoloured, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  J&J dose 7/27/21 (1808980) COVID Positive 10/11/21  10/15/21: History is obtained from patient as well as a personal review of records.  Patient is 47-year-old lady with known history of asthma, obesity pre diabetes and other medical problems.  She lives with her husband and 2 sons.  All 3 of them had COVID-19 in recent past.  Patient started having nasal congestion, chills and cough on 10/7/2021.  Symptoms have become worse in last 2 days.  She is coughing out sputum. Tan and pink in color.  Also reported back pain getting worse with cough and deep breathing.  Patient was advised by primary care provider to go to emergency department. She had test done for  SARS-CoV-2 on 10/11/2021.  It is positive.  She reports getting J&J vaccine.  10/17/21: Patient is a 47-year-old female who originally arrived to the emergency room secondary to some increasing nasal congestion, chills and cough as well as some increasing shortness of breath.  Patient was found to be COVID positive and is noted to have a history of being appropriately vaccinated.  Patient did briefly require some oxygen which ranges anywhere between 2-3 L via nasal cannula.  Patient was started on treatment for COVID-19 with remdesivir, steroids, antibiotics, vitamin-C, vitamin-D and zinc.  Patient did improve.  Patient also received nebulizers and dexamethasone.  On the morning of 10/17/2021 the patient was feeling better and was otherwise felt stable for discharge.  Patient's questions were answered to the best of my abilities and we did discuss review her medications, vital signs, laboratory studies, imaging studies and plan of care as well as the plan for follow-up.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: There was no adverse reaction, vaccine was administered on 02/23/22 and vaccine expired on 02/17.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I experienced shingles.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary congestion, Upper respiratory tract congestion
Clinical narrative: Upper respiratory and lung congestion.
Age: 74.0
Sex: M
Vaccine: VARZOS
Symptoms: Facial pain
Clinical narrative: PT DEVELOPED INTENSE PAIN ON HIS FACE THAT FELT EXACTLY THE WAY IT FELT WHEN HE HAD SHINGLES ON HIS FACE SEVERAL YEARS AGO HOWEVER, THE PAIN WAS ON THE OPPOSITE SIDE OF HIS FACE THAT HE HAD HAD SHINGLES ON. PAIN DEVELOPED WITHIN 24 HOURS OF VACCINATION AND CONTINUED FOR 3 DAYS.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Product administration error, Product storage error, Secretion discharge
Clinical narrative: ADMINISTRATION ERROR:   The vial had the expiration date for ultra cold storage on the vial and was used as the expiration date for the medication.  The vial was stored in the refrigerator and was due to expire before the date given.  Patient reported no ill effects from the vaccine other than coughing and some mucous later that day.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Fatigue, Flushing
Clinical narrative: Initially on March 31 (one week after the vaccine) I had some redness around the injection site but that resolved within a few days.  Then on April 3rd (11 days following the COVID vaccine), I felt very sick. I had chills, nausea, felt very fatigued. Later that day I was feeling very flushed and had diarrhea and felt like I was going to pass out. This happened throughout the afternoon. Symptoms improved by that evening. The following day I had similar symptoms but they were more mild. I had no measured fever at home during this time. My symptoms completely resolved by 4/5/21. On 4/6/21 a new rash started on my left arm around the injection site. It was very warm to touch, uncomfortable but not painful.  Red area is increasing in size and it is raised around the edges. No fevers or chills. I went to the doctor on 4/6 for my symptoms. She prescribed Cephalaxin (Keflex) and ordered a Covid test for me, which was negative.  This description was taken mainly from that after-visit summary.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Injection site discomfort, Injection site erythema, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Initially on March 31 (one week after the vaccine) I had some redness around the injection site but that resolved within a few days.  Then on April 3rd (11 days following the COVID vaccine), I felt very sick. I had chills, nausea, felt very fatigued. Later that day I was feeling very flushed and had diarrhea and felt like I was going to pass out. This happened throughout the afternoon. Symptoms improved by that evening. The following day I had similar symptoms but they were more mild. I had no measured fever at home during this time. My symptoms completely resolved by 4/5/21. On 4/6/21 a new rash started on my left arm around the injection site. It was very warm to touch, uncomfortable but not painful.  Red area is increasing in size and it is raised around the edges. No fevers or chills. I went to the doctor on 4/6 for my symptoms. She prescribed Cephalaxin (Keflex) and ordered a Covid test for me, which was negative.  This description was taken mainly from that after-visit summary.
Age: 48.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Interchange of vaccine products, Malaise, Nausea, SARS-CoV-2 test negative
Clinical narrative: Initially on March 31 (one week after the vaccine) I had some redness around the injection site but that resolved within a few days.  Then on April 3rd (11 days following the COVID vaccine), I felt very sick. I had chills, nausea, felt very fatigued. Later that day I was feeling very flushed and had diarrhea and felt like I was going to pass out. This happened throughout the afternoon. Symptoms improved by that evening. The following day I had similar symptoms but they were more mild. I had no measured fever at home during this time. My symptoms completely resolved by 4/5/21. On 4/6/21 a new rash started on my left arm around the injection site. It was very warm to touch, uncomfortable but not painful.  Red area is increasing in size and it is raised around the edges. No fevers or chills. I went to the doctor on 4/6 for my symptoms. She prescribed Cephalaxin (Keflex) and ordered a Covid test for me, which was negative.  This description was taken mainly from that after-visit summary.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: There was no adverse reaction, vaccine was administered on 02/23/22 and vaccine expired on 02/17.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, Visual impairment
Clinical narrative: My eye seemed blurry. A black film over the eyes and I had a foggy vision.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Autoscopy, Erythema, Fatigue, Mobility decreased, Peripheral swelling
Clinical narrative: Starting around 09:00PM the same day of the vaccine, my arm became very hot, red and swollen. I started getting very tired and I felt like I was having an "out of body experience". I took Tylenol which helped a little temporarily with the aches and pains. I felt this way for 5 days, and for the first 3 days I did not get off the couch except to use the restroom and refill my water.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Skin warm
Clinical narrative: Starting around 09:00PM the same day of the vaccine, my arm became very hot, red and swollen. I started getting very tired and I felt like I was having an "out of body experience". I took Tylenol which helped a little temporarily with the aches and pains. I felt this way for 5 days, and for the first 3 days I did not get off the couch except to use the restroom and refill my water.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Bladder catheterisation, Blood creatinine increased, Blood glucose normal, Blood sodium decreased
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/31/21 (EN6205) Pfizer Dose 2 4/21/21 (EM9809) COVID Positive 11/5/21  11/5/21: Patient is a 66-year-old female who presented to the emergency department today with complaints of dyspnea x1 week.  Reports that she went to urgent care today, and was then referred to the emergency department for hypoxia. Patient reports productive cough, shortness of breath at rest, dyspnea on exertion, fatigue, and decreased appetite over the last 1 week.  Her symptoms have been worse over the last 1-2 days.  She denies any fever, chills, nausea, vomiting, diarrhea.  She has retched a few times when she has coughed hard.  She received the Pfizer COVID vaccine 2-dose series March/April 2021.   On arrival to ED, the patient's SpO2 was 82% on room air. She required 4L of supplemental oxygen to keep her SpO2 greater than 90%.  CXR showed patchy bilateral infiltrates compatible with pneumonia.  Her labs were significant for sodium 129, glucose 183, BUN 29, creatinine 1.36, hemoglobin A1c 6.9%, hemoglobin 8.9, COVID screening positive.  In the ED she received 40 mg IV Lasix, 750 mg Levaquin, and albuterol nebulizer.   On arrival to the floor, the patient has been quite dyspneic.  Cannot quit coughing.  Has had significant stress incontinence.  Cough has been made worse due to frequent bed changes due to incontinence.  I have ordered a Foley catheter at this time.  We will remove it as soon as the patient is stable.  11/11/21: Patient is a 66 y/o female from home. She has a past medical history which includes type 2 DM, HTN, Obesity, OSA, CHF, and CKD stage 3. She was admitted in the hospital on 11/05/21 and treated for covid 19 pneumonia, hypoxia, AKI on CKD , hyperglycemia, and transaminitis secondary to covid pneumonia. The patient was given, neb treatment, IV Lasix and 750 mg IV Levaquin in the ER. She was transfered to the medical unit and  treated with Remdesivir, dexamethasone, IV antibiotic and supplemental O2. Her Sputum culture finalized with MSSA, which was susceptible to Levaquin.   The patient completed her Remdesivir treatment and was able to maintain her oxygen saturation 89/90% on room air. She stated that she just completed a sleep study and has a f/u appointment in a few days. Today she denies shortness of breath. Patient is agreeable to go home.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urea increased, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chronic kidney disease
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/31/21 (EN6205) Pfizer Dose 2 4/21/21 (EM9809) COVID Positive 11/5/21  11/5/21: Patient is a 66-year-old female who presented to the emergency department today with complaints of dyspnea x1 week.  Reports that she went to urgent care today, and was then referred to the emergency department for hypoxia. Patient reports productive cough, shortness of breath at rest, dyspnea on exertion, fatigue, and decreased appetite over the last 1 week.  Her symptoms have been worse over the last 1-2 days.  She denies any fever, chills, nausea, vomiting, diarrhea.  She has retched a few times when she has coughed hard.  She received the Pfizer COVID vaccine 2-dose series March/April 2021.   On arrival to ED, the patient's SpO2 was 82% on room air. She required 4L of supplemental oxygen to keep her SpO2 greater than 90%.  CXR showed patchy bilateral infiltrates compatible with pneumonia.  Her labs were significant for sodium 129, glucose 183, BUN 29, creatinine 1.36, hemoglobin A1c 6.9%, hemoglobin 8.9, COVID screening positive.  In the ED she received 40 mg IV Lasix, 750 mg Levaquin, and albuterol nebulizer.   On arrival to the floor, the patient has been quite dyspneic.  Cannot quit coughing.  Has had significant stress incontinence.  Cough has been made worse due to frequent bed changes due to incontinence.  I have ordered a Foley catheter at this time.  We will remove it as soon as the patient is stable.  11/11/21: Patient is a 66 y/o female from home. She has a past medical history which includes type 2 DM, HTN, Obesity, OSA, CHF, and CKD stage 3. She was admitted in the hospital on 11/05/21 and treated for covid 19 pneumonia, hypoxia, AKI on CKD , hyperglycemia, and transaminitis secondary to covid pneumonia. The patient was given, neb treatment, IV Lasix and 750 mg IV Levaquin in the ER. She was transfered to the medical unit and  treated with Remdesivir, dexamethasone, IV antibiotic and supplemental O2. Her Sputum culture finalized with MSSA, which was susceptible to Levaquin.   The patient completed her Remdesivir treatment and was able to maintain her oxygen saturation 89/90% on room air. She stated that she just completed a sleep study and has a f/u appointment in a few days. Today she denies shortness of breath. Patient is agreeable to go home.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspnoea at rest, Dyspnoea exertional, Fatigue, Glycosylated haemoglobin
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/31/21 (EN6205) Pfizer Dose 2 4/21/21 (EM9809) COVID Positive 11/5/21  11/5/21: Patient is a 66-year-old female who presented to the emergency department today with complaints of dyspnea x1 week.  Reports that she went to urgent care today, and was then referred to the emergency department for hypoxia. Patient reports productive cough, shortness of breath at rest, dyspnea on exertion, fatigue, and decreased appetite over the last 1 week.  Her symptoms have been worse over the last 1-2 days.  She denies any fever, chills, nausea, vomiting, diarrhea.  She has retched a few times when she has coughed hard.  She received the Pfizer COVID vaccine 2-dose series March/April 2021.   On arrival to ED, the patient's SpO2 was 82% on room air. She required 4L of supplemental oxygen to keep her SpO2 greater than 90%.  CXR showed patchy bilateral infiltrates compatible with pneumonia.  Her labs were significant for sodium 129, glucose 183, BUN 29, creatinine 1.36, hemoglobin A1c 6.9%, hemoglobin 8.9, COVID screening positive.  In the ED she received 40 mg IV Lasix, 750 mg Levaquin, and albuterol nebulizer.   On arrival to the floor, the patient has been quite dyspneic.  Cannot quit coughing.  Has had significant stress incontinence.  Cough has been made worse due to frequent bed changes due to incontinence.  I have ordered a Foley catheter at this time.  We will remove it as soon as the patient is stable.  11/11/21: Patient is a 66 y/o female from home. She has a past medical history which includes type 2 DM, HTN, Obesity, OSA, CHF, and CKD stage 3. She was admitted in the hospital on 11/05/21 and treated for covid 19 pneumonia, hypoxia, AKI on CKD , hyperglycemia, and transaminitis secondary to covid pneumonia. The patient was given, neb treatment, IV Lasix and 750 mg IV Levaquin in the ER. She was transfered to the medical unit and  treated with Remdesivir, dexamethasone, IV antibiotic and supplemental O2. Her Sputum culture finalized with MSSA, which was susceptible to Levaquin.   The patient completed her Remdesivir treatment and was able to maintain her oxygen saturation 89/90% on room air. She stated that she just completed a sleep study and has a f/u appointment in a few days. Today she denies shortness of breath. Patient is agreeable to go home.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Haemoglobin decreased, Hyperglycaemia, Hypertransaminasaemia, Hypoxia, Lung infiltration
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/31/21 (EN6205) Pfizer Dose 2 4/21/21 (EM9809) COVID Positive 11/5/21  11/5/21: Patient is a 66-year-old female who presented to the emergency department today with complaints of dyspnea x1 week.  Reports that she went to urgent care today, and was then referred to the emergency department for hypoxia. Patient reports productive cough, shortness of breath at rest, dyspnea on exertion, fatigue, and decreased appetite over the last 1 week.  Her symptoms have been worse over the last 1-2 days.  She denies any fever, chills, nausea, vomiting, diarrhea.  She has retched a few times when she has coughed hard.  She received the Pfizer COVID vaccine 2-dose series March/April 2021.   On arrival to ED, the patient's SpO2 was 82% on room air. She required 4L of supplemental oxygen to keep her SpO2 greater than 90%.  CXR showed patchy bilateral infiltrates compatible with pneumonia.  Her labs were significant for sodium 129, glucose 183, BUN 29, creatinine 1.36, hemoglobin A1c 6.9%, hemoglobin 8.9, COVID screening positive.  In the ED she received 40 mg IV Lasix, 750 mg Levaquin, and albuterol nebulizer.   On arrival to the floor, the patient has been quite dyspneic.  Cannot quit coughing.  Has had significant stress incontinence.  Cough has been made worse due to frequent bed changes due to incontinence.  I have ordered a Foley catheter at this time.  We will remove it as soon as the patient is stable.  11/11/21: Patient is a 66 y/o female from home. She has a past medical history which includes type 2 DM, HTN, Obesity, OSA, CHF, and CKD stage 3. She was admitted in the hospital on 11/05/21 and treated for covid 19 pneumonia, hypoxia, AKI on CKD , hyperglycemia, and transaminitis secondary to covid pneumonia. The patient was given, neb treatment, IV Lasix and 750 mg IV Levaquin in the ER. She was transfered to the medical unit and  treated with Remdesivir, dexamethasone, IV antibiotic and supplemental O2. Her Sputum culture finalized with MSSA, which was susceptible to Levaquin.   The patient completed her Remdesivir treatment and was able to maintain her oxygen saturation 89/90% on room air. She stated that she just completed a sleep study and has a f/u appointment in a few days. Today she denies shortness of breath. Patient is agreeable to go home.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough, Retching, SARS-CoV-2 test positive, Sleep study, Sputum culture positive
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/31/21 (EN6205) Pfizer Dose 2 4/21/21 (EM9809) COVID Positive 11/5/21  11/5/21: Patient is a 66-year-old female who presented to the emergency department today with complaints of dyspnea x1 week.  Reports that she went to urgent care today, and was then referred to the emergency department for hypoxia. Patient reports productive cough, shortness of breath at rest, dyspnea on exertion, fatigue, and decreased appetite over the last 1 week.  Her symptoms have been worse over the last 1-2 days.  She denies any fever, chills, nausea, vomiting, diarrhea.  She has retched a few times when she has coughed hard.  She received the Pfizer COVID vaccine 2-dose series March/April 2021.   On arrival to ED, the patient's SpO2 was 82% on room air. She required 4L of supplemental oxygen to keep her SpO2 greater than 90%.  CXR showed patchy bilateral infiltrates compatible with pneumonia.  Her labs were significant for sodium 129, glucose 183, BUN 29, creatinine 1.36, hemoglobin A1c 6.9%, hemoglobin 8.9, COVID screening positive.  In the ED she received 40 mg IV Lasix, 750 mg Levaquin, and albuterol nebulizer.   On arrival to the floor, the patient has been quite dyspneic.  Cannot quit coughing.  Has had significant stress incontinence.  Cough has been made worse due to frequent bed changes due to incontinence.  I have ordered a Foley catheter at this time.  We will remove it as soon as the patient is stable.  11/11/21: Patient is a 66 y/o female from home. She has a past medical history which includes type 2 DM, HTN, Obesity, OSA, CHF, and CKD stage 3. She was admitted in the hospital on 11/05/21 and treated for covid 19 pneumonia, hypoxia, AKI on CKD , hyperglycemia, and transaminitis secondary to covid pneumonia. The patient was given, neb treatment, IV Lasix and 750 mg IV Levaquin in the ER. She was transfered to the medical unit and  treated with Remdesivir, dexamethasone, IV antibiotic and supplemental O2. Her Sputum culture finalized with MSSA, which was susceptible to Levaquin.   The patient completed her Remdesivir treatment and was able to maintain her oxygen saturation 89/90% on room air. She stated that she just completed a sleep study and has a f/u appointment in a few days. Today she denies shortness of breath. Patient is agreeable to go home.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Staphylococcal infection, Stress urinary incontinence, Vaccine breakthrough infection
Clinical narrative: COVID Vaccine Breakthrough Case  Pfizer Dose 1 3/31/21 (EN6205) Pfizer Dose 2 4/21/21 (EM9809) COVID Positive 11/5/21  11/5/21: Patient is a 66-year-old female who presented to the emergency department today with complaints of dyspnea x1 week.  Reports that she went to urgent care today, and was then referred to the emergency department for hypoxia. Patient reports productive cough, shortness of breath at rest, dyspnea on exertion, fatigue, and decreased appetite over the last 1 week.  Her symptoms have been worse over the last 1-2 days.  She denies any fever, chills, nausea, vomiting, diarrhea.  She has retched a few times when she has coughed hard.  She received the Pfizer COVID vaccine 2-dose series March/April 2021.   On arrival to ED, the patient's SpO2 was 82% on room air. She required 4L of supplemental oxygen to keep her SpO2 greater than 90%.  CXR showed patchy bilateral infiltrates compatible with pneumonia.  Her labs were significant for sodium 129, glucose 183, BUN 29, creatinine 1.36, hemoglobin A1c 6.9%, hemoglobin 8.9, COVID screening positive.  In the ED she received 40 mg IV Lasix, 750 mg Levaquin, and albuterol nebulizer.   On arrival to the floor, the patient has been quite dyspneic.  Cannot quit coughing.  Has had significant stress incontinence.  Cough has been made worse due to frequent bed changes due to incontinence.  I have ordered a Foley catheter at this time.  We will remove it as soon as the patient is stable.  11/11/21: Patient is a 66 y/o female from home. She has a past medical history which includes type 2 DM, HTN, Obesity, OSA, CHF, and CKD stage 3. She was admitted in the hospital on 11/05/21 and treated for covid 19 pneumonia, hypoxia, AKI on CKD , hyperglycemia, and transaminitis secondary to covid pneumonia. The patient was given, neb treatment, IV Lasix and 750 mg IV Levaquin in the ER. She was transfered to the medical unit and  treated with Remdesivir, dexamethasone, IV antibiotic and supplemental O2. Her Sputum culture finalized with MSSA, which was susceptible to Levaquin.   The patient completed her Remdesivir treatment and was able to maintain her oxygen saturation 89/90% on room air. She stated that she just completed a sleep study and has a f/u appointment in a few days. Today she denies shortness of breath. Patient is agreeable to go home.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Pt received an expired dose of Pfizer gray top